U.S., Feb. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07427043) titled 'Robotic Opioid-free Prostatectomy Enhanced Strategy (ROPES)' on Feb. 11.
Brief Summary: This prospective, interventional, open-label, phase 3 randomized study evaluates a multimodal analgesia discharge pathway to reduce automatic opioid prescribing following routine robotic-assisted laparoscopic prostatectomy (RALP). Patients are counseled on post-operative pain management and then may opt into or out of the study with randomization to discharge prescriptions including (A) multimodal plan with additional automatic opioid prescription or (B) multimodal plan alone and instruction to call phone line to request opioid prescription if pa...